{"transactions":[{"id":706447,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":29693,"kind":"person","name":"Yoskowitz Marc J","position":1,"cik":"0001617306","reported_name":"Yoskowitz Marc J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-07-18T01:57:20.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":4406,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon vesting, each restricted stock unit (\"RSU\") will be settled in ordinary shares of the Issuer at one share per RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs will vest on the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual general meeting of shareholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs will vest on the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual general meeting of shareholders."}],"balance_after":9718,"derivative":{"underlying":"Ordinary Shares","underlying_shares":4406},"source":{"system":"sec-edgar","filing":"0001104659-26-084780","document":"tm2620763-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000110465926084780/tm2620763-6_4seq1.xml","form_type":"4"}},{"id":749221,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":29693,"kind":"person","name":"Yoskowitz Marc J","position":1,"cik":"0001617306","reported_name":"Yoskowitz Marc J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-04T20:10:09.000Z","date":"2026-06-02","kind":"exercise","planned":false,"acquired":false,"shares":3579,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") that was settled, was settled in ordinary shares of the Issuer at one share per RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs, which were granted on August 14, 2025 and October 20, 2025, vest on the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual general meeting of shareholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs, which were granted on August 14, 2025 and October 20, 2025, vest on the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual general meeting of shareholders."}],"balance_after":5312,"derivative":{"underlying":"Ordinary Shares","underlying_shares":3579},"source":{"system":"sec-edgar","filing":"0001104659-26-070516","document":"tm2616870-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000110465926070516/tm2616870-1_4seq1.xml","form_type":"4"}},{"id":749220,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":29693,"kind":"person","name":"Yoskowitz Marc J","position":1,"cik":"0001617306","reported_name":"Yoskowitz Marc J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-04T20:10:09.000Z","date":"2026-06-02","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2930,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Reporting Person entered into an agreement with the Issuer pursuant to which the Reporting Person forfeited the right to receive 2,930 RSUs that would otherwise have vested in exchange for a payment from the Issuer to facilitate the Reporting Person's ability to satisfy certain tax obligations related to the RSUs scheduled to vest."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The number of RSUs forfeited is based on a percentage."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs, which were granted on August 14, 2025 and October 20, 2025, vest on the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual general meeting of shareholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs, which were granted on August 14, 2025 and October 20, 2025, vest on the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual general meeting of shareholders."}],"balance_after":8891,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2930},"source":{"system":"sec-edgar","filing":"0001104659-26-070516","document":"tm2616870-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000110465926070516/tm2616870-1_4seq1.xml","form_type":"4"}},{"id":749219,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":29693,"kind":"person","name":"Yoskowitz Marc J","position":1,"cik":"0001617306","reported_name":"Yoskowitz Marc J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-04T20:10:09.000Z","date":"2026-06-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":825,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The number of ordinary shares withheld to satisfy tax withholding obligations arising out the vesting of RSUs is based on a percentage and did not take into account any market value as the Issuer's ordinary shares are not listed or quoted on a recognized trading market."}],"balance_after":3541,"source":{"system":"sec-edgar","filing":"0001104659-26-070516","document":"tm2616870-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000110465926070516/tm2616870-1_4seq1.xml","form_type":"4"}},{"id":749218,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":29693,"kind":"person","name":"Yoskowitz Marc J","position":1,"cik":"0001617306","reported_name":"Yoskowitz Marc J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-04T20:10:09.000Z","date":"2026-06-02","kind":"exercise","planned":false,"acquired":true,"shares":3579,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") that was settled, was settled in ordinary shares of the Issuer at one share per RSU."}],"balance_after":4366,"source":{"system":"sec-edgar","filing":"0001104659-26-070516","document":"tm2616870-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000110465926070516/tm2616870-1_4seq1.xml","form_type":"4"}},{"id":876536,"issuer":{"id":7264,"kind":"organization","name":"Mereo BioPharma Group plc"},"owners":[{"id":29693,"kind":"person","name":"Yoskowitz Marc J","position":1,"cik":"0001617306","reported_name":"Yoskowitz Marc J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Restricted Stock Units","published_at":"2026-02-27T21:30:29.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":96163,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Deferred restricted stock units (\"DRSU\") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Deferred restricted stock units (\"DRSU\") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Deferred restricted stock units (\"DRSU\") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Deferred restricted stock units (\"DRSU\") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Each American Depositary Share (\"ADS\") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer."}],"balance_after":96163,"derivative":{"underlying":"American Depository Shares","underlying_shares":96163},"source":{"system":"sec-edgar","filing":"0001193125-26-082830","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1617306/000119312526082830/ownership.xml","form_type":"4"}},{"id":876535,"issuer":{"id":7264,"kind":"organization","name":"Mereo BioPharma Group plc"},"owners":[{"id":29693,"kind":"person","name":"Yoskowitz Marc J","position":1,"cik":"0001617306","reported_name":"Yoskowitz Marc J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Options (Right to buy)","published_at":"2026-02-27T21:30:29.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":66000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests in substantially equal monthly installments over a one year period from the February 26, 2026 grant date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Each American Depositary Share (\"ADS\") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer."}],"balance_after":66000,"derivative":{"exercise_price":0.39,"expiration_date":"2036-02-26","underlying":"American Depositary Shares","underlying_shares":66000},"source":{"system":"sec-edgar","filing":"0001193125-26-082830","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1617306/000119312526082830/ownership.xml","form_type":"4"}},{"id":881417,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":29693,"kind":"person","name":"Yoskowitz Marc J","position":1,"cik":"0001617306","reported_name":"Yoskowitz Marc J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-02-26T01:57:27.000Z","date":"2026-02-23","kind":"grant","planned":false,"acquired":true,"shares":5312,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon vesting, each restricted stock unit (\"RSU\") will be settled in ordinary shares of the Issuer at one share per RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each RSU will fully vest on February 23, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each RSU will fully vest on February 23, 2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects that the Reporting Person received 1,093 additional RSUs resulting from the adjustment of the RSUs held by the Reporting Person immediately prior to the separation of Par Health, Inc. (\"Par Health\") from the Issuer on November 10, 2025, pursuant to the terms of the Employee Matters Agreement by and between the Issuer and Par Health."}],"balance_after":11821,"derivative":{"underlying":"Ordinary Shares","underlying_shares":5312},"source":{"system":"sec-edgar","filing":"0001104659-26-019927","document":"tm267115-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000110465926019927/tm267115-7_4seq1.xml","form_type":"4"}},{"id":1015736,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":29693,"kind":"person","name":"Yoskowitz Marc J","position":1,"cik":"0001617306","reported_name":"Yoskowitz Marc J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-10-21T00:01:05.000Z","date":"2025-10-20","kind":"grant","planned":false,"acquired":true,"shares":1354,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon vesting, each restricted stock unit (\"RSU\") will be settled in ordinary shares of the Issuer at one share per RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs will vest on the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual general meeting of shareholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs will vest on the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual general meeting of shareholders."}],"balance_after":5416,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1354},"source":{"system":"sec-edgar","filing":"0001104659-25-100948","document":"tm2529059-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000110465925100948/tm2529059-1_4seq1.xml","form_type":"4"}},{"id":1063545,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":29693,"kind":"person","name":"Yoskowitz Marc J","position":1,"cik":"0001617306","reported_name":"Yoskowitz Marc J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-08-19T01:06:47.000Z","date":"2025-08-14","kind":"grant","planned":false,"acquired":true,"shares":4062,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon vesting, each restricted stock unit (\"RSU\") will be settled in ordinary shares of the Issuer at one share per RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs will vest on the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual general meeting of shareholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs will vest on the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual general meeting of shareholders."}],"balance_after":4062,"derivative":{"underlying":"Ordinary Shares","underlying_shares":4062},"source":{"system":"sec-edgar","filing":"0001104659-25-079949","document":"tm2523680-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000110465925079949/tm2523680-8_4seq1.xml","form_type":"4"}},{"id":1280008,"issuer":{"id":7264,"kind":"organization","name":"Mereo BioPharma Group plc"},"owners":[{"id":29693,"kind":"person","name":"Yoskowitz Marc J","position":1,"cik":"0001617306","reported_name":"Yoskowitz Marc J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Restricted Stock Units","published_at":"2025-02-06T21:30:22.000Z","date":"2025-02-05","kind":"grant","planned":false,"acquired":true,"shares":13719,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Deferred restricted stock units (\"DRSU\") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Deferred restricted stock units (\"DRSU\") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Deferred restricted stock units (\"DRSU\") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Deferred restricted stock units (\"DRSU\") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Each American Depositary Share (\"ADS\") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer"}],"balance_after":13719,"derivative":{"underlying":"American Depository Shares","underlying_shares":13719},"source":{"system":"sec-edgar","filing":"0000950170-25-015426","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1617306/000095017025015426/ownership.xml","form_type":"4"}},{"id":1280007,"issuer":{"id":7264,"kind":"organization","name":"Mereo BioPharma Group plc"},"owners":[{"id":29693,"kind":"person","name":"Yoskowitz Marc J","position":1,"cik":"0001617306","reported_name":"Yoskowitz Marc J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Options (Right to buy)","published_at":"2025-02-06T21:30:22.000Z","date":"2025-02-05","kind":"grant","planned":false,"acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests in substantially equal monthly installments over a one year period from the February 5, 2025 grant date"},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Each American Depositary Share (\"ADS\") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer"}],"balance_after":55000,"derivative":{"exercise_price":3.16,"expiration_date":"2035-02-05","underlying":"American Depositary Shares","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0000950170-25-015426","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1617306/000095017025015426/ownership.xml","form_type":"4"}},{"id":1651175,"issuer":{"id":7264,"kind":"organization","name":"Mereo BioPharma Group plc"},"owners":[{"id":29693,"kind":"person","name":"Yoskowitz Marc J","position":1,"cik":"0001617306","reported_name":"Yoskowitz Marc J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Restricted Stock Units","published_at":"2024-02-09T21:15:26.000Z","date":"2024-02-08","kind":"grant","planned":false,"acquired":true,"shares":14139,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Deferred restricted stock units (\"DRSU\") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Deferred restricted stock units (\"DRSU\") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Deferred restricted stock units (\"DRSU\") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Deferred restricted stock units (\"DRSU\") are granted to non-executive directors who elected to receive DRSUs in the form of ADSs in lieu of annual cash compensation. DRSUs vest in substantially equal monthly installments over the plan year following the grant date. Payment of DRSUs in ADSs will generally be made 180 days following separation of service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Each American Depositary Share (\"ADS\") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer."}],"balance_after":14139,"derivative":{"underlying":"American Depository Shares","underlying_shares":14139},"source":{"system":"sec-edgar","filing":"0000950170-24-013269","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1617306/000095017024013269/ownership.xml","form_type":"4"}},{"id":1651174,"issuer":{"id":7264,"kind":"organization","name":"Mereo BioPharma Group plc"},"owners":[{"id":29693,"kind":"person","name":"Yoskowitz Marc J","position":1,"cik":"0001617306","reported_name":"Yoskowitz Marc J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Options (Right to buy)","published_at":"2024-02-09T21:15:26.000Z","date":"2024-02-08","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests in substantially equal monthly installments over a one year period from the February 8, 2024 grant date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Each American Depositary Share (\"ADS\") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer."}],"balance_after":45000,"derivative":{"exercise_price":3.87,"expiration_date":"2034-02-08","underlying":"American Depository Shares","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0000950170-24-013269","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1617306/000095017024013269/ownership.xml","form_type":"4"}}]}